ALLO
Price
$1.24
Change
-$0.02 (-1.59%)
Updated
Nov 20, 04:59 PM (EDT)
Capitalization
277.54M
104 days until earnings call
Intraday BUY SELL Signals
CRBU
Price
$1.75
Change
-$0.07 (-3.85%)
Updated
Nov 20, 04:59 PM (EDT)
Capitalization
170.11M
116 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALLO vs CRBU

Header iconALLO vs CRBU Comparison
Open Charts ALLO vs CRBUBanner chart's image
Allogene Therapeutics
Price$1.24
Change-$0.02 (-1.59%)
Volume$8.89K
Capitalization277.54M
Caribou Biosciences
Price$1.75
Change-$0.07 (-3.85%)
Volume$8.31K
Capitalization170.11M
ALLO vs CRBU Comparison Chart in %
ALLO
Daily Signal:
Gain/Loss:
CRBU
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ALLO vs. CRBU commentary
Nov 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLO is a Hold and CRBU is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 21, 2025
Stock price -- (ALLO: $1.24 vs. CRBU: $1.82)
Brand notoriety: ALLO and CRBU are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLO: 93% vs. CRBU: 33%
Market capitalization -- ALLO: $277.54M vs. CRBU: $170.11M
ALLO [@Biotechnology] is valued at $277.54M. CRBU’s [@Biotechnology] market capitalization is $170.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.15B to $0. The average market capitalization across the [@Biotechnology] industry is $2.12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLO’s FA Score shows that 0 FA rating(s) are green whileCRBU’s FA Score has 1 green FA rating(s).

  • ALLO’s FA Score: 0 green, 5 red.
  • CRBU’s FA Score: 1 green, 4 red.
According to our system of comparison, CRBU is a better buy in the long-term than ALLO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLO’s TA Score shows that 6 TA indicator(s) are bullish while CRBU’s TA Score has 4 bullish TA indicator(s).

  • ALLO’s TA Score: 6 bullish, 4 bearish.
  • CRBU’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ALLO is a better buy in the short-term than CRBU.

Price Growth

ALLO (@Biotechnology) experienced а +2.92% price change this week, while CRBU (@Biotechnology) price change was -19.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.65%. For the same industry, the average monthly price growth was -7.08%, and the average quarterly price growth was +60.39%.

Reported Earning Dates

ALLO is expected to report earnings on Mar 04, 2026.

CRBU is expected to report earnings on Mar 16, 2026.

Industries' Descriptions

@Biotechnology (-1.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALLO($278M) has a higher market cap than CRBU($170M). CRBU YTD gains are higher at: 14.465 vs. ALLO (-42.019). CRBU has higher annual earnings (EBITDA): -150.76M vs. ALLO (-223.22M). ALLO has more cash in the bank: 273M vs. CRBU (184M). CRBU has less debt than ALLO: CRBU (25.9M) vs ALLO (79.2M). CRBU has higher revenues than ALLO: CRBU (9.12M) vs ALLO (0).
ALLOCRBUALLO / CRBU
Capitalization278M170M164%
EBITDA-223.22M-150.76M148%
Gain YTD-42.01914.465-290%
P/E RatioN/AN/A-
Revenue09.12M-
Total Cash273M184M148%
Total Debt79.2M25.9M306%
FUNDAMENTALS RATINGS
ALLO: Fundamental Ratings
ALLO
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALLOCRBU
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
69%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
70%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 24 days ago
81%
Bullish Trend 9 days ago
80%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 7 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
ALLO
Daily Signal:
Gain/Loss:
CRBU
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BYSD0.87N/A
N/A
Bayside Corp.
BCKIF15.01-0.22
-1.44%
Babcock International Group Plc
ONTTF1.68-0.04
-2.33%
Oxford Nanopore Technologies PLC
KYCCF332.50-11.93
-3.46%
Keyence Corp.
RECAF0.36-0.02
-4.48%
Reconnaissance Energy Africa Ltd.

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with CRSP. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
-2.67%
CRSP - CRBU
59%
Loosely correlated
-5.12%
RXRX - CRBU
53%
Loosely correlated
-3.12%
BEAM - CRBU
52%
Loosely correlated
-4.24%
MGNX - CRBU
51%
Loosely correlated
-7.79%
AXON - CRBU
50%
Loosely correlated
-0.50%
More